Use your antibodies-online credentials, if available.
No Products on your Comparison List.
Your basket is empty.
Find out more
Show all species
Show all synonyms
Select your species and application
anti-Human CXCL2 Antibodies:
anti-Mouse (Murine) CXCL2 Antibodies:
anti-Rat (Rattus) CXCL2 Antibodies:
Go to our pre-filtered search.
Mouse (Murine) Polyclonal CXCL2 Primary Antibody for Func, IHC (fro) - ABIN2475709
Hollifield, Page, Smith, Michelakis, Staab, Rhamy: Renin-secreting clear cell carcinoma of the kidney. in Archives of internal medicine 1975
Show all 4 Pubmed References
Mouse (Murine) Polyclonal CXCL2 Primary Antibody for IHC (fro), IHC (p) - ABIN2475710
Di Carlo, Comes, Basso, De Ambrosis, Meazza, Musiani, Moelling, Albini, Ferrini: The combined action of IL-15 and IL-12 gene transfer can induce tumor cell rejection without T and NK cell involvement. in Journal of immunology (Baltimore, Md. : 1950) 2000
Show all 4 Pubmed References
Rat (Rattus) Polyclonal CXCL2 Primary Antibody for IP, WB - ABIN110547
Frevert, Farone, Danaee, Paulauskis, Kobzik: Functional characterization of rat chemokine macrophage inflammatory protein-2. in Inflammation 1995
Show all 2 Pubmed References
Cow (Bovine) Polyclonal CXCL2 Primary Antibody for IHC, ELISA - ABIN1582230
Oue, Lee, Sakamoto, Iimura, Aoki, Kayamori, Michi, Yamashiro, Harada, Amagasa, Yamaguchi: CXCL2 synthesized by oral squamous cell carcinoma is involved in cancer-associated bone destruction. in Biochemical and biophysical research communications 2012
Human Polyclonal CXCL2 Primary Antibody for ELISA, WB - ABIN4274954
De Filippo, Henderson, Laschinger, Hogg: Neutrophil chemokines KC and macrophage-inflammatory protein-2 are newly synthesized by tissue macrophages using distinct TLR signaling pathways. in Journal of immunology (Baltimore, Md. : 1950) 2008
Mouse (Murine) Polyclonal CXCL2 Primary Antibody for Neut, ELISA - ABIN223564
Asarias, Nguyen, Mings, Gehrich, Pierce: Influence of mesh materials on the expression of mediators involved in wound healing. in Journal of investigative surgery : the official journal of the Academy of Surgical Research 2011
Mouse (Murine) Polyclonal CXCL2 Primary Antibody for EIA, WB - ABIN116266
Sterzenbach, Lee, Brenneke, von Goetz, Schauer, Fox, Suerbaum, Josenhans: Inhibitory effect of enterohepatic Helicobacter hepaticus on innate immune responses of mouse intestinal epithelial cells. in Infection and immunity 2007
Show all 2 Pubmed References
Mouse (Murine) Polyclonal CXCL2 Primary Antibody for EIA, WB - ABIN116265
Gonzalez-Rey, Chorny, Robledo, Delgado: Cortistatin, a new antiinflammatory peptide with therapeutic effect on lethal endotoxemia. in The Journal of experimental medicine 2006
Show all 2 Pubmed References
Human Polyclonal CXCL2 Primary Antibody for Func, IHC (p) - ABIN2473896
Haskill, Peace, Morris, Sporn, Anisowicz, Lee, Smith, Martin, Ralph, Sager: Identification of three related human GRO genes encoding cytokine functions. in Proceedings of the National Academy of Sciences of the United States of America 1990
Show all 3 Pubmed References
Rat (Rattus) Polyclonal CXCL2 Primary Antibody for Func, ELISA - ABIN2473897
Vallès, Grijpink-Ongering, de Bree, Tuinstra, Ronken: Differential regulation of the CXCR2 chemokine network in rat brain trauma: implications for neuroimmune interactions and neuronal survival. in Neurobiology of disease 2006
Functional effects data suggested that recombinant human CXCL2 significantly enhanced the migration, invasion ability of SMMC7721 hepatocellular carcinoma cells, and weakened adhesion ability.
Reduced rate of sickle-related complications in Brazilian patients carrying HbF-promoting alleles at the BCL11A (show BCL11A Antibodies) and HMIP (show MIPEP Antibodies)-2 loci
Results identify the CXCL2/MIF (show AMH Antibodies)-CXCR2 (show CXCR2 Antibodies) axis as an important mediator in MDSC recruitment and as predictors in bladder cancer.
Chronic inflammation contributes to the change of CXCL12 (show CXCL12 Antibodies) DNA methylation (show HELLS Antibodies) in buccal cells and that DNA methylation (show HELLS Antibodies) profile of CXCL12 (show CXCL12 Antibodies) promoter plays important role in development and progression of periodontal disease.
Polymorphisms in the promoter regions of the CXCL1 (show CXCL1 Antibodies) and CXCL2 genes contribute to increased risk of alopecia areata in the Korean population
In this review, a genetic variant in CXCL12 (show CXCL12 Antibodies) is described that is associated with type 2 diabetes mellitus and its complications.
We have demonstrated that GRObeta, as an oncogene (show RAB1A Antibodies) product, contributed to tumorigenesis and metastasis of HCC (show FAM126A Antibodies)
Our results demonstrated that resistance to anti-proliferative effects of CXCR2 (show CXCR2 Antibodies) may also arise from feedback increases in MIP-2 secretion.
autophagy is required for Hepatitis B virus-induced NF-kappaB (show NFKB1 Antibodies) activation and release of IL-6 (show IL6 Antibodies), IL-8 (show IL8 Antibodies), and CXCL2 in Hepatocytes
The results link CXCL1 (show CXCL1 Antibodies) and CXCL2 chemokines with bone marrow adiposity and implicate CXCR2 (show CXCR2 Antibodies) signaling in promoting effects of marrow fat on progression of skeletal tumors in bone.
mip-2 siRNA and the MIP-2 antibody can reduce the inflammatory effects induced by lipopolysaccharide in macrophage cells.
this study demonstrates that in vivo blocking of CXCL1 (show CXCL1 Antibodies) and CXCL2 can significantly reduce the Mycobacterium tuberculosis-induced bioactive IL-1beta (show IL1B Antibodies) production
These data identify suppression of CXCL2 and CXCL5 (show CXCL5 Antibodies) chemoattractant expression by 11beta-HSD1 (show HSD11B1 Antibodies) as a novel mechanism with potential for regulation of neutrophil recruitment to the injured myocardium, and cardiac fibroblasts as a key site for intracellular glucocorticoid regeneration during acute inflammation following myocardial injury.
findings show that SRC-3 (show NCOA3 Antibodies) contributes to host defense against enteric bacteria, at least in part via upregulating CXCL2 expression to recruit neutrophils
p53 (show TP53 Antibodies)-mediated induction of PAI-1 (show SERPINE1 Antibodies) expression due to chronic CS exposure exacerbates lung inflammation through elaboration of CXCL1 (show CXCL1 Antibodies), CXCL2, and CXCR2 (show CXCR2 Antibodies).
Social defeat induced an exposure-dependent increase in mRNA levels of E-selectin (show SELE Antibodies), CXCL1 (show CXCL1 Antibodies), and CXCL2 that increased with additional days of social defeat.
MIP-2 directly impairs neonatal pulmonary endothelial cell migration in vitro.
These results have suggested that the activation of MyD88 (show MYD88 Antibodies) pathway by constitutive low-level IL-1beta (show IL1B Antibodies) expression is essential for pressure force-induced CXCL2 and CCL2 (show CCL2 Antibodies) expression in osteoblasts.
SIRT2 (show SIRT2 Antibodies) regulates LPS (show TLR4 Antibodies) induced proximal renal tubules CXCL2 protein expression.
miR26a/-26b-COX-2 (show COX2 Antibodies)-MIP-2 loop regulates allergic inflammation and the feedback relationship between allergic inflammation and the enhanced tumorigenic and metastatic potential
reports transmural and perivascular expression patterns of chemokines CCL2 (show CCL2 Antibodies) and CXCL2 and of chemokine (show CCL1 Antibodies) receptors CCR2 (show CCR2 Antibodies), CCR5, and CXCR4 (show CXCR4 Antibodies) following coronary angioplasty
Results suggested that chemokine (show CCL1 Antibodies) expression by cultured equine BECs following exposure to pulmonary hemorrhage conditions may contribute to the development of inflammatory airway disease in horses.
This study examined effects of in vitro exposure to solutions of hay (show GTF2H5 Antibodies) dust, lipopolysaccharides, or beta-glucan on cytokine expression in pulmonary mononuclear cells isolated from healthy horses and horses with recurrent airway obstruction.
Produced by activated monocytes and neutrophils and expressed at sites of inflammation. Hematoregulatory chemokine, which, in vitro, suppresses hematopoietic progenitor cell proliferation. GRO-beta(5-73) shows a highly enhanced hematopoietic activity.
C-X-C motif chemokine 2
, GRO2 oncogene
, MGSA beta
, growth-regulated protein beta
, macrophage inflammatory protein 2-alpha
, melanoma growth stimulatory activity beta
, GRO3 oncogene
, GRO3, growth related gene 3
, growth-regulated protein homolog gamma
, macrophage inflammatory protein 2
, small inducible cytokine subfamily, member 2
, cytokine-induced neutrophil chemoattractant 3
, chemokine ligand 2